Publication: Real-Time Adherence Monitoring for HIV Antiretroviral Therapy
Open/View Files
Date
2010
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer US
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Haberer, Jessica E., Josh Kahane, Isaac Kigozi, Nneka Emenyonu, Peter Hunt, Jeffrey Martin, and David R. Bangsberg. 2010. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS and Behavior 14(6): 1340-1346.
Research Data
Abstract
Current adherence assessments typically detect missed doses long after they occur. Real-time, wireless monitoring strategies for antiretroviral therapy may provide novel opportunities to proactively prevent virologic rebound and treatment failure. Wisepill, a wireless pill container that transmits a cellular signal when opened, was pilot tested in ten Ugandan individuals for 6 months. Adherence levels measured by Wisepill, unannounced pill counts, and self-report were compared with each other, prior standard electronic monitoring, and HIV RNA. Wisepill data was initially limited by battery life and signal transmission interruptions. Following device improvements, continuous data was achieved with median (interquartile range) adherence levels of 93% (87–97%) by Wisepill, 100% (99–100%) by unannounced pill count, 100% (100–100%) by self-report, and 92% (79–98%) by prior standard electronic monitoring. Four individuals developed transient, low-level viremia. After overcoming technical challenges, real-time adherence monitoring is feasible for resource-limited settings and may detect suboptimal adherence prior to viral rebound.
Description
Other Available Sources
Keywords
wireless technology, real-time adherence monitoring, antiretroviral therapy
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service